Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.02 per share a year ago.

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates

- Grew Q2 2023 Preliminary Revenue 18% and Preliminary Adjusted EBITDA 23% vs. Q2 2022 - - Evaluating Programs to Cull Approximately 10% of the Corporate Portfolio -

The Joint Corp. Reports Preliminary Second Quarter 2023 Financial Results

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced the company intends to restate previously issued audited financial statements as of and for the year ending December 31, 2022 contained in the Annual Report on Form 10-K for the year ended December 31, 2022 and the unaudited interim financial statements contained in the Quarterly Reports on Form 10-Q for the quarters and cumulative periods ended June 30, 2022, and September 30, 2022 (the “Previously Issued Financial Statements”) related to the reacquisition of regional developer rights and transfer pricing adjustments for the Company's variable interest entities.

The Joint Corp. Provides Updates on the June 30, 2023 SEC 10-Q Filing

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., Aug. 25, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced it received a delinquency notification letter from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) on August 22, 2023 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).

The Joint Corp. Announces Receipt of Delinquency Notification Letter from Nasdaq

- Franchise and digital marketing expert  with vast experience increasing customer acquisition -  SCOTTSDALE, Ariz. , Aug. 14, 2023 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announces the hiring of Lori Abou Habib, as its new Chief Marketing Officer.

The Joint Corp. Hires Lori Abou Habib as New Chief Marketing Officer

– System-wide Sales Grew 13% to $120.1 Million – – Unrestricted Cash $13.6 Million at June 30, 2023, Compared to $9.7 Million at December 31, 2022 – – Increased Clinics to 890 at June 30, 2023 and Achieved the 900 Clinic Milestone in August 2023 –

The Joint Corp. Reports Second Quarter 2023 Operating Highlights

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

SCOTTSDALE, Ariz., Aug. 7, 2023 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through  The Joint Chiropractic®  network, is delighted to announce the opening of its 900th clinic, accomplishing a significant growth benchmark less than one year after celebrating 800 location openings last September.

The Joint Chiropractic Marks Expansion Milestone with 900th Clinic Opening

Joint Corp. will report earnings on Aug. 10. The company's stock is down >70% in the past two years. The business model may lack punch, but even so the low valuation may be unjustified.

The Joint Corp.: Cracking Upside Bet, Or Creaking Business Model?

SCOTTSDALE, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2023 financial results on Thursday, August 10, 2023, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results

The Joint (JYNT) is expected to keep growing due to rising patient visits and new clinic openings.

Here's Why Hold Strategy is Apt for The Joint (JYNT) Stock Now

SCOTTSDALE, Ariz. , June 22, 2023 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic®  network, announces a new collaboration with K9s For Warriors, a nonprofit organization that pairs highly trained service dogs with military Veterans suffering from service-connected traumas.

The Joint Chiropractic Joins K9s For Warriors in Supporting Military Veterans

The Joint (JYNT) expects the Wisconsin region to hold a total of 53 clinics, of which 21 are currently operating.

The Joint (JYNT) Buys Wisconsin Regional Developer Zone Rights

SCOTTSDALE, Ariz., June 20, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, acquired the regional developer (RD) territory rights for Wisconsin for $950,000 on June 15, 2023.

The Joint Corp. Acquires Wisconsin Regional Developer Territory Rights

The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Joint Corp. (JYNT) Surges 10.0%: Is This an Indication of Further Gains?

The Joint Corp. (NASDAQ:JYNT ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CFO Conference Call Participants Jeremy Hamblin - Craig-Hallum Capital Group Jeff Van Sinderen - B. Riley George Kelly - ROTH Capital Partners Anthony Vendetti - Maxim Group Operator Good day, and welcome to The Joint Corp. First Quarter 2023 Financial Results Conference Call.

The Joint Corp. (JYNT) Q1 2023 Earnings Call Transcript

- Grew Q1 2023 Revenue 27%, System-wide Sales 17% and System-wide Comp Sales 8% vs. Q1 2022 - - Increased Clinic Count to 870, Including 130 Company-Owned or Managed Clinics, at March 31, 2023 -

The Joint Corp. Reports First Quarter 2023 Financial Results

SCOTTSDALE, Ariz., April 20, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its first quarter 2023 financial results on Thursday, May 4, 2023, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, May 4th to Discuss First Quarter 2023 Results

-Husband-and-wife team are multi-unit franchisees of The Joint in Houston- SCOTTSDALE, Ariz. , March 28, 2023 /PRNewswire/ -- The Joint Corp. (NASDQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announces Noah Stone and Vy Tran as the International Franchise Association's (IFA) 2023 Franchisee of the Year.

Noah Stone and Vy Tran of The Joint Chiropractic Awarded Franchisee of the Year by International Franchise Association

The Puerto Rico deal with the Comerfords marks The Joint's (JYNT) first franchise deal outside the continental United States.

The Joint (JYNT) to Enter Puerto Rico With New Franchise Deal

-First of two clinics is scheduled to open in Fall 2023-  SCOTTSDALE, Ariz. , March 17, 2023 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has signed its first franchise agreement outside the continental United States.

Military Husband and Wife Team Set to Expand The Joint Chiropractic into Puerto Rico

SCOTTSDALE, Ariz., March 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced James H. Amos, Jr. has notified the company that he will complete his term on May 25, 2023 and not stand for reelection at the company's 2023 Annual Meeting of Stockholders scheduled for that day. The board membership will be reduced to six until a replacement is appointed or elected.

The Joint Corp. Thanks Retiring Board Member James H. Amos, Jr.

The Joint Corp. (NASDAQ:JYNT ) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CFO Conference Call Participants Jeff Van Sinderen - B. Riley FBR Anthony Vendetti - Maxim Group George Kelly - ROTH Capital Partners Brooks O'Neil - Lake Street Capital Markets Linda Bolton Weiser - DA Davidson Operator Good day, and welcome to The Joint Fourth Quarter 2022 Financial Results Conference Call.

The Joint Corp. (JYNT) Q4 2022 Earnings Call Transcript

The Joint Corp. (JYNT) delivered earnings and revenue surprises of -42.86% and 1.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Joint Stock (JYNT)